Skip to main content

Anne L. Bruno


[email protected]



Anne is a seasoned attorney whose practice spans several areas of corporate and employment law. She has extensive experience advising clients, ranging from startups to multinational public companies, in a broad range of industries, on issues related to executive compensation, employee benefits, securities law, and corporate governance.

Part of Anne’s practice involves helping clients create, implement and administer equity and executive compensation arrangements and programs, including equity plans, phantom equity arrangements, incentive plans, change in control arrangements, and severance and employment agreements.  She also advises with respect to tax, corporate and securities law concerns that arise in connection with such plans and arrangements. She advises and represents a broad range of public and private companies, boards of directors and compensation committees in these matters. She also assists executives with negotiation of their compensation packages.

In the corporate side of her practice, Anne regularly counsels clients on the intricacies of the federal securities laws. She assists public companies in complying with the Securities Exchange Act of 1934, including required disclosure filings and shareholder materials. Her particular knowledge of SEC reporting requirements extends to evolving rules regarding disclosure of director and executive compensation, cybersecurity and privacy matters and environmental, social and governance factors.  In addition, Anne assists companies in implementing and administering a range of policies to address governance obligations, including insider trading, hedging and claw back policies.  She also provides guidance on Securities Act of 1933 requirements to clients involved in public and privately placed equity and debt financings and in connection with merger and acquisition transactions.



  • Harvard University (JD, cum laude)
  • Brown University (AB, magna cum laude)

Recognition & Awards

  • Phi Beta Kappa


Webinar Reference Image

Webinar Recording: Hot Topics in Employee Benefits and Executive Compensation: What's New in 2022?

February 9, 2022 | Webinar | By Michelle Capezza, David Lagasse, Anne Bruno, Alden Bianchi

In this webinar, members from our Employee Benefits & Executive Compensation Practice discuss the latest in how employers must continue to manage their benefits and compensation programs to attract and retain talent. Hear our attorneys talk about 2022 trends in benefits and compensation and how companies should address the wide array of compliance issues affecting their programs.
Read more
Securities & Capital Markets Viewpoints Thumbnail

Preparation for 2021 Fiscal Year-End SEC Filings and 2022 Annual Shareholder Meetings

January 18, 2022 | Advisory | By Megan Gates, John Condon, Anne Bruno, Melanie Ruthrauff Levy, Daniel T. Kajunski, Cynthia Larose, Breton Leone-Quick, Page R. Hubben

Read about key regulatory and other developments, including board diversity and other ESG matters, which public companies need to consider as they prepare for their fiscal year-end SEC filings and 2022 annual shareholder meetings.
Read more
Securities & Capital Markets Viewpoints Thumbnail
This advisory provides some background on Governor Baker’s COVID executive order, issued in March 2020, and outlines what its expiration will mean for Massachusetts public companies planning shareholder meetings.
Read more
Securities & Capital Markets Viewpoints Thumbnail

Preparation for 2020 Fiscal Year-End SEC Filings and 2021 Annual Shareholder Meetings

January 21, 2021 | Advisory | By Megan Gates, John Condon, Daniel T. Kajunski, Anne Bruno

Read about regulatory and other developments public companies need to consider as they prepare for fiscal year-end Securities and Exchange Commission filings and 2021 annual shareholder meetings.
Read more
Employment, Labor, and Benefits Viewpoints Thumbnail
Read the transcript of’s November 2020 webcast titled, “Pay Equity: What Compensation Committees Need to Know” in which Anne L. Bruno was among the experts to discuss pay equity, shareholder expectations, disclosure trends, board oversight, and more.
Read more
Securities & Capital Markets Viewpoints Thumbnail

How Companies Can Prepare for SEC Proxy Advisor Reform

January 12, 2021 | Advisory | By Anne Bruno

This advisory discusses the SEC’s final rules — effective November 2, 2020 — governing voting advice provided by proxy advisory firms such as Institutional Shareholders Service (ISS) and Glass Lewis.
Read more
Securities & Capital Markets Viewpoints Thumbnail

Disclosure Considerations Regarding Operations, Liquidity, and Capital Resources

July 21, 2020 | Advisory | By Anne Bruno, Ginny H. Lee

This advisory discusses the SEC’s recent guidance on operations, liquidity, and capital resources disclosure that companies should consider in light of the COVID-19 pandemic.
Read more
Securities & Capital Markets Viewpoints Thumbnail
This advisory summarizes recent proxy advisor guidance on and strategies for adjusting annual performance goals in light of the COVID-19 pandemic.
Read more
Coronavirus Molecule

Executive Compensation: Moving Forward in a COVID-19 World

June 2, 2020 | Blog | By Alexander Song, Anne Bruno, Michael Arnold, Steve Gulotta, Andrew Bernstein

Employers reacted in a variety of ways to cope with the unprecedented financial impact of COVID-19.  Employers must begin to shift their focus to whether their current executive compensation practices are designed with sufficient incentives to retain key employees and to spur recovery and sustained growth.  This post reviews the range of cost-cutting measures companies have enacted over the past few months, and provides guidance on executive compensation issues employers should consider as they move forward in a COVID-19 world.
Read more

News & Press

Press Release Thumbnail
Mintz advised Cardurion Pharmaceuticals, Inc., a biotechnology company developing novel therapeutics to treat heart failure and other cardiovascular diseases, in a private investment of up to $300 million from Bain Capital Life Sciences and Bain Capital Private Equity that will enable the Boston-based company to expand its drug discovery programs.
News Thumbnail
In Agenda, a Financial Times publication, Mintz Special Counsel Anne Bruno was quoted on company succession planning and how boards can effectively communicate the process and decision to candidates.
Press Release Thumbnail
Firm plays a key role in the largest health care acquisition to date in 2020.